FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Markus Schwaninger

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Anatomy

Physiology

Procedures

Immunohistochemistry

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Dirk A Ridder; Markus Schwaninger
TAK1 inhibition for treatment of cerebral ischemia.
Dirk A Ridder; Markus Schwaninger
In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease.
Panagiotis Bargiotas; Antje Krenz; Hannah Monyer; Markus Schwaninger
Functional outcome of pannexin-deficient mice after cerebral ischemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Markus Schwaninger (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Dirk A Ridder; Markus Schwaninger
TAK1 inhibition for treatment of cerebral ischemia.
Experimental neurology 2013;239():68-72.
2012: Dirk A Ridder; Markus Schwaninger
In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease.
Experimental neurology 2012;238(2):133-7.
2012: Panagiotis Bargiotas; Antje Krenz; Hannah Monyer; Markus Schwaninger
Functional outcome of pannexin-deficient mice after cerebral ischemia.
Channels (Austin, Tex.) 2012;6(6):453-6.
2012: Panagiotis Bargiotas; Elke Fuchs; Nurith Jakob; Hannah Monyer; Sajjad Muhammad; Nikolaus Plesnila; Mahbubur Rahman; Lothar Schilling; Raimund Trabold; Markus Schwaninger
Connexin 36 promotes cortical spreading depolarization and ischemic brain damage.
Brain research 2012;1479():80-5.
2012: Zdenka Djuric; Thomas Fleming; Markus Hecker; Stephan Herzig; Berend Isermann; Muhammed Kashif; Sajjad Muhammad; David Piel; Marina Pizzi; Markus Schwaninger; Rüdiger von Bauer; Martin Zeier; Florian Bea; Angelika Bierhaus; Peter P Nawroth
Targeting activation of specific NF-κB subunits prevents stress-dependent atherothrombotic gene expression.
Molecular medicine (Cambridge, Mass.) 2012;18():1375-86.
2011: Sheng-Jia Zhang; Bettina Buchthal; David Lau; Stefanie Hayer; Oliver Dick; Markus Schwaninger; Roland Veltkamp; Ming Zou; Ursula Weiss; Hilmar Bading
A signaling cascade of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene repression module that protects against extrasynaptic NMDA receptor-induced neuronal cell death and ischemic brain damage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2011;31(13):4978-90.
2011: Sajjad Muhammad; Emanuel Haasbach; Maria Kotchourko; Anne Strigli; Antje Krenz; Dirk A Ridder; Annette B Vogel; Hugo H Marti; Yousef Al-Abed; Oliver Planz; Markus Schwaninger
Influenza virus infection aggravates stroke outcome.
Stroke; a journal of cerebral circulation 2011;42(3):783-91.
2011: Katharina Schindowski; Oliver von Bohlen und Halbach; Jens Strelau; Dirk A Ridder; Oliver Herrmann; Andreas Schober; Markus Schwaninger; Klaus Unsicker
Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia.
Cell and tissue research 2011;343(2):399-409.
2011: Marion N Schölzke; Amely Röttinger; Sasidhar Murikinati; Nadine Gehrig; Christoph Leib; Markus Schwaninger
TWEAK regulates proliferation and differentiation of adult neural progenitor cells.
Molecular and cellular neurosciences 2011;46(1):325-32.
2010: Katrin Frauenknecht; Panagiotis Bargiotas; Henrike Bauer; Philipp von Landenberg; Markus Schwaninger; Clemens Sommer
Neuroprotective effect of Fn14 deficiency is associated with induction of the granulocyte-colony stimulating factor (G-CSF) pathway in experimental stroke and enhanced by a pathogenic human antiphospholipid antibody.
Journal of neuroimmunology 2010;227(1-2):1-9.
2010: S Muhammad; M Isabel Aller; Christiane Maser-Gluth; Markus Schwaninger; william wisden
Expression of the kcnk3 potassium channel gene lessens the injury from cerebral ischemia, most likely by a general influence on blood pressure.
Neuroscience 2010;167(3):758-64.
2010: Franziska Rompe; Metin Artuc; Anders Hallberg; Mathias Alterman; Katja Ströder; Christa Thöne-Reineke; Anne Reichenbach; Jens Schacherl; Björn Dahlöf; Michael Bader; Natalia Alenina; Markus Schwaninger; Torsten Zuberbier; Heiko Funke-Kaiser; Cosima Schmidt; Wolf-Hagen Schunck; Thomas Unger; U Muscha Steckelings
Direct angiotensin II type 2 receptor stimulation acts anti-inflammatory through epoxyeicosatrienoic acid and inhibition of nuclear factor kappaB.
Hypertension 2010;55(4):924-31.
2010: Sasidhar Murikinati; Eric Jüttler; Timo Keinert; Dirk A Ridder; Sajjad Muhammad; Zoe Waibler; Catherine Ledent; Andreas Zimmer; Ulrich Kalinke; Markus Schwaninger
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(3):788-98.
2009: Judith Lubjuhn; Alexandra Gastens; Gertrud von Wilpert; Panagiotis Bargiotas; Oliver Herrmann; Sasidhar Murikinati; Tamer Rabie; Hugo H Marti; Hugo Marti; Ivo Amende; Tom G Hampton; Markus Schwaninger
Functional testing in a mouse stroke model induced by occlusion of the distal middle cerebral artery.
Journal of neuroscience methods 2009;184(1):95-103.
2009: Waleed Barakat; Oliver Herrmann; Bernd Baumann; Markus Schwaninger
NF-kappaB induces PGE2-synthesizing enzymes in neurons.
Naunyn-Schmiedeberg's archives of pharmacology 2009;380(2):153-60.
2009: Dirk A Ridder; Svetlana Bulashevska; Ganta Vijay Chaitanya; Phanithi Prakash Babu; Benedikt Brors; Roland Eils; Armin Schneider; Markus Schwaninger
Discovery of transcriptional programs in cerebral ischemia by in silico promoter analysis.
Brain research 2009;1272():3-13.
2009: Ioana Inta; Daniela Weber; Christina Grundt; Roland Veltkamp; Susanne Winteroll; Gerd U Auffarth; Markus Bettendorf; Björn Lemmer; Markus Schwaninger
Correlation of soluble gp130 serum concentrations with arterial blood pressure.
Journal of hypertension 2009;27(3):527-34.
2009: Panagiotis Bargiotas; Hannah Monyer; Markus Schwaninger
Hemichannels in cerebral ischemia.
Current molecular medicine 2009;9(2):186-94.
2009: Sajjad Muhammad; Angelika Bierhaus; Markus Schwaninger
Reactive oxygen species in diabetes-induced vascular damage, stroke, and Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2009;16(4):775-85.
2008: Ioana Inta; Katrin Frauenknecht; Henrike Dörr; Patricia Kohlhof; Tanja Rabsilber; Gerd U Auffarth; Linda Burkly; Michel Mittelbronn; Kyungmin Hahm; Clemens Sommer; Markus Schwaninger
Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
Journal of the neurological sciences 2008;275(1-2):117-20.
2008: Sajjad Muhammad; Waleed Barakat; Stoyan Stoyanov; Sasidhar Murikinati; Huan Yang; Kevin Tracey; Martin Bendszus; Grazisa Rossetti; Peter P Nawroth; Angelika Bierhaus; Markus Schwaninger
The HMGB1 receptor RAGE mediates ischemic brain damage.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(46):12023-31.
2008: Peter Teschendorf; Markus Albertsmeier; Peter Vogel; Stephan A Padosch; Fabian Spöhr; Michael Kirschfink; Markus Schwaninger; Bernd W Böttiger; Erik Popp
Neurological outcome and inflammation after cardiac arrest--effects of protein C in rats.
Resuscitation 2008;79(2):316-24.
2008: Ming-Fei Lang; Armin Schneider; Carola Krüger; Roland Schmid; Roman Dziarski; Markus Schwaninger
Peptidoglycan recognition protein-S (PGRP-S) is upregulated by NF-kappaB.
Neuroscience letters 2008;430(2):138-41.
2008: Matthias Endres; Britta Engelhardt; Jari Koistinaho; Olle Lindvall; Stephen Meairs; Jay P Mohr; Anna Planas; Nancy Rothwell; Markus Schwaninger; Martin E Schwab; Denis Vivien; Tadeusz Wieloch; Ulrich Dirnagl
Improving outcome after stroke: overcoming the translational roadblock.
Cerebrovascular diseases (Basel, Switzerland) 2008;25(3):268-78.
2007: Eric Jüttler; Ioana Inta; Verena Eigler; Oliver Herrmann; Ira Maegele; Christiane Maser-Gluth; Markus Schwaninger
Neuronal NF-kappaB influences thermoregulation and survival in a sepsis model.
Journal of neuroimmunology 2007;189(1-2):41-9.
2007: Marion N Schölzke; Markus Schwaninger
Transcriptional regulation of neurogenesis: potential mechanisms in cerebral ischemia.
Journal of molecular medicine (Berlin, Germany) 2007;85(6):577-88.
2006: Ioana Inta; Stephan Paxian; Ira Maegele; Wen Zhang; Marina Pizzi; PierFranco Spano; Ilenia Sarnico; Sajjad Muhammad; Oliver Herrmann; Dragos Inta; Bernd Baumann; Hsiou-Chi Liou; Roland M Schmid; Markus Schwaninger
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2006;26(50):12896-903.
2006: Markus Schwaninger; Ioana Inta; Oliver Herrmann
NF-kappaB signalling in cerebral ischaemia.
Biochemical Society transactions 2006;34(Pt 6):1291-4.
2006: JUAN JOSE MARTIN; Ingrid Hausser; Philippe Lyrer; Otto Busse; Ralf Schwarz; Rolf Schneider; Tobias Brandt; Manja Kloss; Markus Schwaninger; Stefan Engelter; Caspar Grond-Ginsbach
Familial cervical artery dissections: clinical, morphologic, and genetic studies.
Stroke; a journal of cerebral circulation 2006;37(12):2924-9.
2006: Daniela Roesch-Ely; Stephan Weiland; Hans Scheffel; Markus Schwaninger; Hans-Peter Hundemer; Thomas Kolter; Matthias Weisbrod
Dopaminergic modulation of semantic priming in healthy volunteers.
Biological psychiatry 2006;60(6):604-11.
2006: Jennifer Diedler; S Rieger; A Koch; S Parthé-Peterhans; Markus Schwaninger
Bilateral facial palsy: Epstein-Barr virus, not Lyme disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(9):1029-30.
2006: Sabine Chourbaji; Alexandre Urani; Ioana Inta; CARLA SANCHIS-SEGURA; Christiane Brandwein; Mathias Zink; Markus Schwaninger; Peter Gass
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors.
Neurobiology of disease 2006;23(3):587-94.
2006: Roland Veltkamp; Li Sun; Oliver Herrmann; Guido Wolferts; Sebastien Hagmann; Dirk A Siebing; Hugo H Marti; Claudia Veltkamp; Markus Schwaninger
Oxygen therapy in permanent brain ischemia: potential and limitations.
Brain research 2006;1107(1):185-91.
2006: Christian Jacobi; Christian Schwark; Bodo Kress; Andreas Hug; Brigitte Storch-Hagenlocher; Markus Schwaninger
Subarachnoid hemorrhage due to Borrelia burgdorferi-associated vasculitis.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(5):536-8.
2006: Roland Veltkamp; Katja Bieber; Simone Wagner; Christopher Beynon; Dirk A Siebing; Claudia Veltkamp; Markus Schwaninger; Hugo H Marti
Hyperbaric oxygen reduces basal lamina degradation after transient focal cerebral ischemia in rats.
Brain research 2006;1076(1):231-7.
2005: M Isabel Aller; Emma L Veale; Anni-Maija Linden; Cristina Sandu; Markus Schwaninger; Louisa J Evans; Esa R Korpi; Alistair Mathie; william wisden; Stephen G Brickley
Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2005;25(49):11455-67.
2005: Oliver Herrmann; Bernd Baumann; Rossana De Lorenzi; Sajjad Muhammad; Wen Zhang; Jens Kleesiek; Max Malfertheiner; Martin Köhrmann; Ioana Potrovita; Ira Maegele; Cordian Beyer; James R Burke; Mazahir T Hasan; Hermann Bujard; Thomas Wirth; Manolis Pasparakis; Markus Schwaninger
IKK mediates ischemia-induced neuronal death.
Nature medicine 2005;11(12):1322-9.
2005: Roland Veltkamp; Dirk A Siebing; Li Sun; Sabine Heiland; Katja Bieber; Hugo H Marti; Simon Nagel; Stefan Schwab; Markus Schwaninger
Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia.
Stroke; a journal of cerebral circulation 2005;36(8):1679-83.
2005: Peter A Ringleb; E I Strittmatter; M Loewer; M Hartmann; Jochen B Fiebach; Christoph Lichy; R Weber; C Jacobi; K Amendt; Markus Schwaninger
Cerebrovascular manifestations of Takayasu arteritis in Europe.
Rheumatology (Oxford, England) 2005;44(8):1012-5.
2005: Daniela Roesch-Ely; Hans Scheffel; Stephan Weiland; Markus Schwaninger; Hans-Peter Hundemer; Thomas Kolter; Matthias Weisbrod
Differential dopaminergic modulation of executive control in healthy subjects.
Psychopharmacology 2005;178(4):420-30.
2005: Roland Veltkamp; Dirk A Siebing; Sabine Heiland; Philip Schoenffeldt-Varas; Claudia Veltkamp; Markus Schwaninger; Stefan Schwab
Hyperbaric oxygen induces rapid protection against focal cerebral ischemia.
Brain research 2005;1037(1-2):134-8.
2005: Peter A Ringleb; Christian Schwark; Markus Schwaninger; Peter D Schellinger
Efficacy and costs of secondary prevention with antiplatelets after ischaemic stroke.
Expert opinion on pharmacotherapy 2005;6(3):359-67.
2005: Wen Zhang; Ioana Potrovita; Victoria Tarabin; Oliver Herrmann; Verena Beer; Falk Weih; Armin Schneider; Markus Schwaninger
Neuronal activation of NF-kappaB contributes to cell death in cerebral ischemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2005;25(1):30-40.
2004: Angelika Bierhaus; Karl-Matthias Haslbeck; Per M Humpert; Birgit Liliensiek; Thomas Dehmer; Michael Morcos; Ahmed A R Sayed; Martin Andrassy; Stephan Schiekofer; Jochen G Schneider; Jörg B Schulz; Dieter Heuss; Bernhard Neundörfer; Stefan Dierl; Jochen Huber; Hans Tritschler; Ann Marie Schmidt; Markus Schwaninger; Hans-Ulrich Haering; Erwin Schleicher; Michael Kasper; David M Stern; Bernd Arnold; Peter P Nawroth
Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.
The Journal of clinical investigation 2004;114(12):1741-51.
2004: Irina Kiprianova; Katharina Schindowski; Oliver von Bohlen und Halbach; Sonja Krause; Rosanna Dono; Markus Schwaninger; Klaus Unsicker
Enlarged infarct volume and loss of BDNF mRNA induction following brain ischemia in mice lacking FGF-2.
Experimental neurology 2004;189(2):252-60.
2004: Ioana Potrovita; Wen Zhang; Linda C Burkly; Kyungmin Hahm; John Lincecum; Monica Z Wang; Martin H Maurer; Moritz Rossner; Armin Schneider; Markus Schwaninger
Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(38):8237-44.
2004: Florian Dvorak; Francisco Martinez-Torres; Johann Sellner; Jürgen Haas; Peter D Schellinger; Markus Schwaninger; Uta Meyding-Lamadé
Experimental herpes simplex virus encephalitis: a long-term study of interleukin-6 expression in mouse brain tissue.
Neuroscience letters 2004;367(3):289-92.
2004: Eric Jüttler; Ioana Potrovita; Victoria Tarabin; Simone Prinz; Tuan Dong-Si; George Fink; Markus Schwaninger
The cannabinoid dexanabinol is an inhibitor of the nuclear factor-kappa B (NF-kappa B).
Neuropharmacology 2004;47(4):580-92.
2004: Victoria Tarabin; Markus Schwaninger
The role of NF-kappaB in 6-hydroxydopamine- and TNFalpha-induced apoptosis of PC12 cells.
Naunyn-Schmiedeberg's archives of pharmacology 2004;369(6):563-9.
2004: Marc-André Weber; Christian Jacobi; Brigitte Storch-Hagenlocher; Markus Schwaninger; P Schramm
[Acute paraplegia].
Der Radiologe 2004;44(4):376-9.
2004: Antti Nurmi; Perttu J Lindsberg; Milla Koistinaho; Wen Zhang; Eric Juettler; Marja-Liisa Karjalainen-Lindsberg; Falk Weih; Norbert Frank; Markus Schwaninger; Jari Koistinaho
Nuclear factor-kappaB contributes to infarction after permanent focal ischemia.
Stroke; a journal of cerebral circulation 2004;35(4):987-91.
2004: Armin Schneider; Rico Laage; Oliver von Ahsen; Achim Fischer; Moritz Rossner; Sigrid Scheek; Sylvia Grünewald; Rohini Kuner; Daniela Weber; Carola Krüger; Bettina Klaussner; Bernhard Götz; Holger Hiemisch; Dieter Newrzella; Ana Martin Villalba; Alfred Bach; Markus Schwaninger
Identification of regulated genes during permanent focal cerebral ischaemia: characterization of the protein kinase 9b5/MARKL1/MARK4.
Journal of neurochemistry 2004;88(5):1114-26.
2004: Roland Veltkamp; Claudia Veltkamp; Marius Hartmann; Ph Schönffeldt-Varas; Markus Schwaninger
[Symptomatic dissection of the internal carotid artery. A rare manifestation of autosome dominant polycystic kidney disease?].
Der Nervenarzt 2004;75(2):149-52.
2004: Armin Schneider; Achim Fischer; Daniela Weber; Oliver von Ahsen; Sigrid Scheek; Carola Krüger; Moritz Rossner; Bettina Klaussner; Nadine Faucheron; Birgitta Kammandel; Bernhard Goetz; Oliver Herrmann; Alfred Bach; Markus Schwaninger
Restriction-mediated differential display (RMDD) identifies pip92 as a pro-apoptotic gene product induced during focal cerebral ischemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2004;24(2):224-36.
2003: Marion N Schölzke; Ioana Potrovita; Srinivasa Subramaniam; Simone Prinz; Markus Schwaninger
Glutamate activates NF-kappaB through calpain in neurons.
The European journal of neuroscience 2003;18(12):3305-10.
2003: Fabian Meisel; Christian Jacobi; Rainer Kollmar; Andreas Hug; Markus Schwaninger; Stefan Schwab
[Acute meningitis after transrectal prostate biopsy].
Der Urologe. Ausg. A 2003;42(12):1611-5.
2003: Veronika Butterweck; Simone Prinz; Markus Schwaninger
The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice.
Behavioural brain research 2003;144(1-2):49-56.
2003: Daniela Acalovschi; Tina Wiest; Marius Hartmann; Maryam Farahmi; Ulrich Mansmann; Gerd U Auffarth; Armin J Grau; Fiona R Green; Caspar Grond-Ginsbach; Markus Schwaninger
Multiple levels of regulation of the interleukin-6 system in stroke.
Stroke; a journal of cerebral circulation 2003;34(8):1864-9.
2003: Armin J Grau; Markus Schwaninger; H H Goebel; M Beck
[Fabry's disease: new therapeutic options for this lysosomal storage disorder].
Der Nervenarzt 2003;74(6):489-96.
2003: Oliver Herrmann; Victoria Tarabin; Shigeaki Suzuki; Nicolas Attigah; Irinel Coserea; Armin Schneider; Johannes Vogel; Simone Prinz; Stefan Schwab; Hannah Monyer; Frank Brombacher; Markus Schwaninger
Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2003;23(4):406-15.
2003: Wolf-Rüdiger Schäbitz; Katharina Glatz; Christian Schuhan; Clemens Sommer; Christian Berger; Markus Schwaninger; Marius Hartmann; Hans Hilmar Goebel; Hans-Michael Meinck
Severe forward flexion of the trunk in Parkinson's disease: focal myopathy of the paraspinal muscles mimicking camptocormia.
Movement disorders : official journal of the Movement Disorder Society 2003;18(4):408-14.
2003: Wolf-Rüdiger Schäbitz; Rainer Kollmar; Markus Schwaninger; Eric Juettler; Juergen Bardutzky; Marion N Schölzke; Clemens Sommer; Stefan Schwab
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.
Stroke; a journal of cerebral circulation 2003;34(3):745-51.
2003: Angelika Bierhaus; Jutta Wolf; Martin Andrassy; Nicolas Rohleder; Per M Humpert; Dmitry Petrov; Roman Ferstl; Maximilian von Eynatten; Thoralf Wendt; Gottfried Rudofsky; Martina Joswig; Michael Morcos; Markus Schwaninger; Bruce McEwen; Clemens Kirschbaum; Peter P Nawroth
A mechanism converting psychosocial stress into mononuclear cell activation.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(4):1920-5.
2002: Rainer Kollmar; Peter D Schellinger; Juergen Bardutzky; Fabian Meisel; Markus Schwaninger
[Myxedema coma as a rare differential diagnosis of severe consciousness disturbance].
Der Nervenarzt 2002;73(12):1183-5.
2002: R Heller; Armin J Grau; Wolf-Rüdiger Schäbitz; Markus Schwaninger
[Cerebrotendinous xanthomatosis, a treatable metabolic disorder].
Der Nervenarzt 2002;73(12):1160-6.
2002: Alexander Gutschalk; Rainer Kollmar; Alexander Mohr; Marcus Henze; Nicole Ille; Markus Schwaninger; Marius Hartmann; Stefan Hähnel; Uwe Haberkorn; André Rupp; Uta Meyding-Lamade
Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine.
Neuroscience letters 2002;332(2):115-8.
2002: Simone Wagner; Pamela Kalb; Martina Lukosava; Ulrich Hilgenfeldt; Markus Schwaninger
Activation of the tissue kallikrein-kinin system in stroke.
Journal of the neurological sciences 2002;202(1-2):75-6.
2002: Daniela Roesch-Ely; Regina W von Einsiedel; Sven Kathöfer; Markus Schwaninger; Matthias Weisbrod
Myocarditis with quetiapine.
The American journal of psychiatry 2002;159(9):1607-8.
2002: Wolf-Rüdiger Schäbitz; Andrea Giuffrida; Christian Berger; Alfred Aschoff; Markus Schwaninger; Stefan Schwab; Daniele Piomelli
Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study.
Stroke; a journal of cerebral circulation 2002;33(8):2112-4.
2002: Eric Jüttler; Victoria Tarabin; Markus Schwaninger
Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity.
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2002;8(3):268-75.
2001: Angelika Bierhaus; Stephan Schiekofer; Markus Schwaninger; Martin Andrassy; Per M Humpert; Jiang Chen; M Hong; Thomas Luther; Thomas Henle; I Klöting; Michael Morcos; Michael Hofmann; Hans Tritschler; B Weigle; Michael Kasper; Mark A. Smith; George Perry; Ann Marie Schmidt; David M Stern; Hans-Ulrich Häring; Erwin Schleicher; Peter P Nawroth
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
Diabetes 2001;50(12):2792-808.
2001: Peter Teismann; Markus Schwaninger; Falk Weih; Boris Ferger
Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease.
Neuroreport 2001;12(5):1049-53.
2000: S Sallmann; Eric Jüttler; Simone Prinz; N Petersen; U Knopf; T Weiser; Markus Schwaninger
Induction of interleukin-6 by depolarization of neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(23):8637-42.
2000: Wolf-Rüdiger Schäbitz; Clemens Sommer; W Zoder; Marika Kiessling; Markus Schwaninger; Stefan Schwab
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia.
Stroke; a journal of cerebral circulation 2000;31(9):2212-7.
2000: Markus Schwaninger; N Petersen; Simone Prinz; S Sallmann; Markus Neher; Matthias Spranger
Adenosine-induced expression of interleukin-6 in astrocytes through protein kinase A and NF-IL-6.
Glia 2000;31(1):51-8.
1999: Markus Schwaninger; S Sallmann; N Petersen; Armin Schneider; Simone Prinz; Towia Libermann; Matthias Spranger
Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB.
Journal of neurochemistry 1999;73(4):1461-6.
1999: Armin Schneider; Ana Martin Villalba; Falk Weih; Johannes Vogel; T Wirth; Markus Schwaninger
NF-kappaB is activated and promotes cell death in focal cerebral ischemia.
Nature medicine 1999;5(5):554-9.
1998: Markus Schwaninger; Matthias Weisbrod; S Schwab; M Schröder; W Hacke
Hypothermia induced by atypical neuroleptics.
Clinical neuropharmacology 1998;21(6):344-6.
1997: Markus Schwaninger; Markus Neher; E Viegas; Armin Schneider; Matthias Spranger
Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine.
Journal of neurochemistry 1997;69(3):1145-50.